Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam therapy have fewer instances of bone marrow toxicity than patients who receive the standard treatment of intensity-modulated radiation (IMRT) and concurrent chemotherapy, according to researchers from The University of Texas M. D. Anderson Cancer Center.
(more…)
Tags: Anderson Cancer Center, Bone Cancer, Bone Marrow Toxicity, Cancer Chemotherapy, Cancer Therapy, Cell Lung Cancer, Chemotherapy, Chemotherapy Patients, Imrt, Instances, Intensity Modulated Radiation, Lung Cancer, M D Anderson, M D Anderson Cancer Center, Non Small Cell Lung Cancer, Proton Beam Therapy, Proton Therapy, Small Cell Lung Cancer, University Of Texas, University Of Texas M D Anderson Cancer Center
Genentech, Inc. (NYSE:DNA) and OSI Pharmaceuticals, Inc. (Nasdaq:OSIP) today announced that a global Phase III study (SATURN) met its primary endpoint and showed Tarceva® (erlotinib) significantly extended the time patients with advanced non-small cell lung cancer (NSCLC) lived without their cancer getting worse when given immediately following initial treatment with platinum-based chemotherapy, compared to placebo.
(more…)
Tags: Cell Lung Cancer, Chemotherapy, Endpoint, Erlotinib, Free Survival, Genentech Inc, Global Phase, Initial Treatment, Line Maintenance, Lung Cancer, Maintenance Therapy, Nasdaq, Non Small Cell Lung Cancer, Nyse, Osi Pharmaceuticals Inc, Phase Iii, Small Cell Lung Cancer, Study Saturn, Tarceva, Time Patients
Reuters - An international research team has identified two genetic variations that appear to increase a person's risk of developing lung cancer by up to 60 percent, they reported on Sunday.
(more…)
Tags: Cancer Research, Genes, Genetic Variations, International Research Team, Lung Cancer, Lung Cancer Risk, Reuters, Scientists
AFP - Scientists in the United States have identified 26 genes whose mutation plays a role in the commonest form of lung cancer, including genes that may be receptive to novel drugs or existing treatments used to tackle other tumours.
(more…)
Tags: Cancer Genes, Culprits, Lung Cancer, Mutation, Novel Drugs, Plays, Scientists, Trawl, Tumours, United States
HealthDay - WEDNESDAY, Oct. 22 (HealthDay News) — Researchers have
identified 26 genes associated with the most common type of lung cancer,
adenocarcinoma — more than doubling the number of genes known to play a
role in the deadly disease.
(more…)
Tags: Adenocarcinoma, Deadly Disease, Genes, Healthday News Researchers, Lung Cancer, Type Of Lung Cancer
AP - In the largest effort of its kind, scientists have identified 26 genes that, when damaged, appear to promote lung cancer.
(more…)
Tags: Genes, Lung Cancer, Scientists
Reuters - An international research team has identified two genetic variations that appear to increase a person's risk of developing lung cancer by up to 60 percent, they reported on Sunday.
(more…)
Tags: Cancer Research, Genes, Genetic Variations, International Research Team, Lung Cancer, Lung Cancer Risk, Reuters, Scientists
Red Wine Can Reduce Lung Cancer Risks
(more…)
Tags: Cancer Lung, Lung Cancer, Lung Cancer Risks, Red Wine
Yale Cancer Center researchers have identified a genetic biomarker that may help to determine why some people are at an increased risk of developing lung cancer. The findings, published in the journal Cancer Research, could help identify smokers who should be carefully screened for lung cancer.
(more…)
Tags: Biomarker, Cancer Help, Cancer Research, Center Researchers, Genetic Marker, Journal Cancer, Lung Cancer, Lung Cancer Risk, Marker, Smokers, Yale Cancer Center, Yale Scientists
HealthDay - TUESDAY, Oct. 14 (HealthDay News) — New details about the
structure of a virus that can infect lung cancer cells have been uncovered
by researchers at the Scripps Research Institute in California.
(more…)
Tags: Healthday, Lung Cancer, Lung Cancer Cells, New Details, Scientists, Scripps Research Institute, Scripps Research Institute In California, Structure Of A Virus
Drinking red wine not only reduces your risk for cardiovascular disease, but it may also reduce your risk for lung cancer especially if you are a current or ex-smoker, Reuters reported Thursday.
(more…)
Tags: Cardiovascular Disease, Lung Cancer, Red Wine, Reuters, Risk, Smoker
Drinking red wine not only reduces your risk for cardiovascular disease, but it may also reduce your risk for lung cancer especially if you are a current or ex-smoker, Reuters reported Thursday.
(more…)
Tags: Cardiovascular Disease, Lung Cancer, Red Wine, Reuters, Risk, Smoker
Reuters - Drinking red wine, but not white wine, may reduce lung cancer risk, especially among current and ex-smokers, new research indicates.
(more…)
Tags: Lung Cancer, Lung Cancer Risk, Lung Cancer Study, Red Wine, Reuters, Smokers, White Wine
Reuters - Japanese investigators say that survival rates are better for patients with non-small cell lung cancer (NSCLC) who never smoked than in NSCLC patients with a history of smoking. Other disease characteristics are different as well between the two populations.
(more…)
Tags: Cancer Disease, Cell Lung Cancer, Disease Characteristics, History Of Smoking, Japanese Investigators, Lung Cancer, Non Small Cell Lung Cancer, Nsclc, Populations, Reuters, Small Cell Lung Cancer, Smokers, Smoking Disease, Survival Rates
Reuters - Japanese investigators say that survival rates are better for patients with non-small cell lung cancer (NSCLC) who never smoked than in NSCLC patients with a history of smoking. Other disease characteristics are different as well between the two populations.
(more…)
Tags: Cancer Disease, Cell Lung Cancer, Disease Characteristics, History Of Smoking, Japanese Investigators, Lung Cancer, Non Small Cell Lung Cancer, Nsclc, Populations, Reuters, Small Cell Lung Cancer, Smokers, Smoking Disease, Survival Rates
Reuters - Japanese investigators say that survival rates are better for patients with non-small cell lung cancer (NSCLC) who never smoked than in NSCLC patients with a history of smoking. Other disease characteristics are different as well between the two populations.
(more…)
Tags: Cancer Disease, Cell Lung Cancer, Disease Characteristics, History Of Smoking, Japanese Investigators, Lung Cancer, Non Small Cell Lung Cancer, Nsclc, Populations, Reuters, Small Cell Lung Cancer, Smokers, Smoking Disease, Survival Rates
NEW YORK (Reuters Health) - Drinking red wine, but not white wine, may reduce lung cancer risk, especially among current and ex-smokers, new research indicates.
Tags: Lung Cancer, Lung Cancer Risk, Lung Cancer Study, Red Wine, Reuters Health, Smokers, White Wine
HealthDay - TUESDAY, Oct. 7 (HealthDay News) — Men who drink a moderate amount of
red wine may lower their risk of lung cancer, even if they smoke,
researchers report.
(more…)
Tags: 7 News, Healthday, Lung Cancer, Oct 7, Red Wine, Risk
HealthDay - TUESDAY, Oct. 7 (HealthDay News) — Men who drink a moderate amount of
red wine may lower their risk of lung cancer, even if they smoke,
researchers report.
(more…)
Tags: 7 News, Healthday, Lung Cancer, Oct 7, Red Wine, Risk
Genentech, Inc. (NYSE:DNA) and OSI Pharmaceuticals, Inc. (Nasdaq:OSIP) today announced that a randomized Phase III study (BeTa Lung) evaluating Avastin® (bevacizumab) in combination with Tarceva® (erlotinib) in patients with advanced non-small cell lung cancer (NSCLC) whose disease had progressed following platinum-based chemotherapy did not meet its primary endpoint of improving overall survival compared to Tarceva in combination with placebo.
(more…)
Tags: Avastin, Bevacizumab, Cell Lung Cancer, Chemotherapy, Dna, Endpoint, Erlotinib, Genentech Inc, Lung Cancer, Nasdaq, Non Small Cell Lung Cancer, Nsclc, Nyse, Osi Pharmaceuticals Inc, Phase Iii, Placebo, Platinum, Small Cell Lung Cancer, Tarceva, Topline Results